All Stories

  1. Risk to heroin users of polydrug use of pregabalin or gabapentin
  2. Effect of Tamoxifen and Brain-Penetrant Protein Kinase C and c-Jun N-Terminal Kinase Inhibitors on Tolerance to Opioid-Induced Respiratory Depression in Mice
  3. The μ‐opioid receptor: an electrophysiologist's perspective from the sharp end
  4. The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours
  5. Identification of phosphorylation sites in the COOH‐terminal tail of the μ‐opioid receptor
  6. μ‐Opioid receptor desensitization: homologous or heterologous?
  7. Endocytosis of G Protein-Coupled Receptors Is Regulated by Clathrin Light Chain Phosphorylation
  8. Pre-treatment with a PKC or PKA inhibitor prevents the development of morphine tolerance but not physical dependence in mice
  9. Does alcohol increase the risk of overdose death: the need for a translational approach
  10. Methadone: does it really have low efficacy at μ-opioid receptors?
  11. C‐terminal splice variants of the μ‐opioid receptor: existence, distribution and functional characteristics
  12. Evidence for an important role of protein phosphatases in the mechanism of morphine tolerance
  13. How important is protein kinase C in μ-opioid receptor desensitization and morphine tolerance?
  14. The British Pharmacological Society: 75 years old and thriving
  15. Opioid elevation of intracellular free calcium: Possible mechanisms and physiological relevance
  16. 75 years of opioid research: the exciting but vain quest for the Holy Grail
  17. Drug abuse: from gene through cell to behaviour
  18. Co-incident signalling between μ-opioid and M3 muscarinic receptors at the level of Ca2+ release from intracellular stores: lack of evidence for Ins(1,4,5)P3 receptor sensitization
  19. Properties of native P2X receptors in rat trigeminal mesencephalic nucleus neurones: lack of correlation with known, heterologously expressed P2X receptors
  20. Modulation of fast synaptic transmission by presynaptic ligand-gated cation channels
  21. Hyperpolarization‐activated cationic currents (Ih) in neurones of the trigeminal mesencephalic nucleus of the rat
  22. Glycine and GABAA receptor‐mediated synaptic transmission in rat substantia gelatinosa: inhibition by μ‐opioid and GABAB agonists
  23. The orphan opioid receptor and its endogenous ligand — nociceptin/orphanin FQ
  24. Hans Walter Kosterlitz (1903–1996)
  25. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH‐SY5Y human neuroblastoma cells
  26. The effect of nociceptin on Ca2+ channel current and intracellular Ca2+ in the SH‐SY5Y human neuroblastoma cell line
  27. Ca2+ entry following store depletion in SH-SY5Y neuroblastoma cells
  28. δ‐ and μ‐opioid receptor mobilization of intracellular calcium in SH‐SY5Y human neuroblastoma cells
  29. Lack of evidence for coupling of the dopamine D2 receptor to an adenosine triphosphate-sensitive potassium (ATP-K+) channel in dopaminergic neurones of the rat substantia nigra
  30. Activation of μ‐ and δ‐opioid receptors present on the same nerve terminals depresses transmitter release in the mouse hypogastric ganglion
  31. Characterization of two components of the N-like, high-threshold-activated calcium channel current in differentiated SH-SY5Y cells
  32. Complexity of 5-HT pharmacology compounded by electrophysiological data
  33. The ligand rimcazole antagonises (+)SKF 10,047, but not (+)3-PPP, in the mouse isolated vas deferens
  34. Characterization of the neurons of the mouse hypogastric ganglion: morphology and electrophysiology
  35. An examination of the putative σ‐receptor in the mouse isolated vas deferens
  36. Effects of Angiotensin II on [3H]Noradrenaline Release and Phosphatidylinositol Hydrolysis in the Parietal Cortex and Locus Coeruleus of the Rat
  37. Locus Coeruleus Neurons
  38. Substance P excitation of rat locus coeruleus neurones
  39. Graeme Henderson writes in reply:
  40. Phenycyclidine A widely abused but little understood psychotomimetic agent
  41. The effect of extracellular sodium ion concentration on the action of opiates to inhibit potassium-evoked released of [3H]noradrenaline from the mouse vas deferens
  42. Di-isopropyl phosphofluoridate-induced antinociception: possible role of endogenous opioids
  43. In vitro pharmacology of the opioid peptides, enkephalins and endorphins
  44. Action of morphine on guinea-pig myenteric plexus and mouse vas deferens studied by intracellular recording